Related Experiment Video
Updated: Jun 3, 2026
05:54
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
Published on: September 5, 2018
STAT3 signaling: anticancer strategies and challenges.
Paul A Johnston1, Jennifer R Grandis
1School of Pharmaceutical Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Molecular Interventions
|March 29, 2011
Summary
Signal transducer and activator of transcription 3 (STAT3) is a key target in cancer therapy. Inhibiting STAT3 signaling offers promise for treating various human tumors, despite challenges in drug development.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Signal transducer and activator of transcription 3 (STAT3) is implicated in the development, progression, and maintenance of numerous human cancers.
- Activated STAT3 is linked to poor prognosis in many cancer types.
- STAT3 regulates genes critical for cell differentiation, proliferation, apoptosis, angiogenesis, metastasis, and immune responses.
Purpose of the Study:
- To review current approaches targeting STAT3 in cancer therapy.
- To highlight the therapeutic potential and challenges of inhibiting the STAT3 signaling pathway.
Main Methods:
- Literature review of STAT3 targeting strategies in oncology.
- Analysis of the role of STAT3 in cancer pathogenesis and gene regulation.
Main Results:
- STAT3 is a validated anti-cancer target in multiple tumor contexts.
- Elevated STAT3 activation correlates with adverse patient outcomes.
- Various strategies have been explored to therapeutically inhibit STAT3.
Conclusions:
- Targeting STAT3 presents a promising avenue for anti-cancer drug development.
- Challenges remain in developing effective and safe STAT3-inhibiting therapeutics.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.